Exact Mass: 514.2955
Exact Mass Matches: 514.2955
Found 500 metabolites which its exact mass value is equals to given mass value 514.2955
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
elatericin B
Cucurbitacin I is a cucurbitacin that is 9,10,14-trimethyl-4,9-cyclo-9,10-secocholesta-2,5,23-triene substituted by hydroxy groups at positions 2, 16, 20 and 25 and oxo groups at positions 1, 11 and 22. It has a role as a plant metabolite and an antineoplastic agent. It is a cucurbitacin and a tertiary alpha-hydroxy ketone. Cucurbitacin I is a natural product found in Elaeocarpus chinensis, Elaeocarpus hainanensis, and other organisms with data available. A cucurbitacin that is 9,10,14-trimethyl-4,9-cyclo-9,10-secocholesta-2,5,23-triene substituted by hydroxy groups at positions 2, 16, 20 and 25 and oxo groups at positions 1, 11 and 22. Cucurbitacin I is a natural selective inhibitor of JAK2/STAT3, with potent anti-cancer activity.
stigmatellin
A member of the class of chromones that is isolated from Stigmatella aurantiaca Sg a15. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents
Ganoderic acid J
Ganoderic acid J is found in mushrooms. Ganoderic acid J is a metabolite of Ganoderma lucidum (reishi).
Ganoderenic acid B
Ganoderenic acid B is found in mushrooms. Ganoderenic acid B is a constituent of Ganoderma lucidum (reishi) Constituent of Ganoderma lucidum (reishi). Ganoderenic acid B is found in mushrooms. Ganoderenic acid B is a lanostane-type triterpene isolated from Ganoderma lucidum. Ganoderenic acid B exhibits potent reversal effect on ABCB1-mediated multidrug resistance of HepG2/ADM cells to Doxorubicin[1].
Ganoderic acid C1
Ganoderic acid C1 is found in mushrooms. Ganoderic acid C1 is a constituent of Ganoderma lucidum (reishi) Constituent of Ganoderma lucidum (reishi). Ganoderic acid C1 is found in mushrooms. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2]. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2]. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2].
Ganoderenic acid A
Ganoderenic acid A is found in mushrooms. Ganoderenic acid A is a constituent of Ganoderma lucidum (reishi) Constituent of Ganoderma lucidum (reishi). Ganoderenic acid A is found in mushrooms. Ganoderenic acid A is a lanostane-type triterpene. Ganoderenic acid A is a potent inhibitor of β-glucuronidase. Ganoderenic acid A has a potent hepatoprotective effect against CCl4-induced liver injury[1]. Ganoderenic acid A is a lanostane-type triterpene. Ganoderenic acid A is a potent inhibitor of β-glucuronidase. Ganoderenic acid A has a potent hepatoprotective effect against CCl4-induced liver injury[1].
Ganoderic acid xi
Ganoderic acid xi is found in mushrooms. Ganoderic acid xi is a constituent of Ganoderma lucidum (reishi) Constituent of Ganoderma lucidum (reishi). Ganoderic acid xi is found in mushrooms.
Cofaryloside
Cofaryloside is found in coffee and coffee products. Cofaryloside is a constituent of green coffee beans Constituent of green coffee beans. Cofaryloside is found in coffee and coffee products.
Flavidulol C
Flavidulol C is found in mushrooms. Flavidulol C is isolated from the edible, but bitter tasting Japanese kihatsudake mushroom (Lactarius flavidulus). Isolated from the edible, but bitter tasting Japanese kihatsudake mushroom (Lactarius flavidulus). Flavidulol C is found in mushrooms.
Ganoderic acid V1
Ganoderic acid V1 is found in mushrooms. Ganoderic acid V1 is a metabolite of Ganoderma lucidum (reishi). Metabolite of Ganoderma lucidum (reishi). Ganoderic acid V1 is found in mushrooms.
Ganosporelactone B
Ganosporelactone B is found in mushrooms. Ganosporelactone B is isolated from the spores of Ganoderma lucidum (reishi).
Capsianoside V
Constituent of fruits of Capsicum annuum variety grossum. Capsianoside V is found in many foods, some of which are orange bell pepper, italian sweet red pepper, red bell pepper, and fruits. Capsianoside V is found in fruits. Capsianoside V is a constituent of fruits of Capsicum annuum var. grossum
Cinncassiol D1 glucoside
Cinncassiol D1 glucoside is found in herbs and spices. Cinncassiol D1 glucoside is a constituent of Cinnamomum cassia (Chinese cinnamon) Constituent of Cinnamomum cassia (Chinese cinnamon). Cinncassiol D1 glucoside is found in herbs and spices.
Cinncassiol D4 2-glucoside
Cinncassiol D4 2-glucoside is found in herbs and spices. Cinncassiol D4 2-glucoside is a constituent of Cinnamomum cassia (Chinese cinnamon) Constituent of Cinnamomum cassia (Chinese cinnamon). Cinncassiol D4 2-glucoside is found in herbs and spices.
N-Docosahexaenoyl Tryptophan
N-docosahexaenoyl tryptophan belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Docosahexaenoyl amide of Tryptophan. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Docosahexaenoyl Tryptophan is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Docosahexaenoyl Tryptophan is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Cucurbitacin I
Ganoderic acid D
Ganoderic acid C1 is a triterpenoid. Ganoderic acid C1 is a natural product found in Ganoderma lucidum with data available. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2]. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2]. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2].
Laulimalide
A macrolide with formula C30H42O7 that is isolated from the marine sponges, Cacospongia mycofijiensis and Hyattella sp.
Ganoderic acid D
Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2]. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2]. Ganoderic acid D, a highly oxygenated tetracyclic triterpenoid, is the major active component of Ganoderma lucidum. Ganoderic acid D upregulates the protein expression of SIRT3 and induces the deacetylated cyclophilin D (CypD) by SIRT3. Ganoderic acid D inhibits the energy reprogramming of colon cancer cells including glucose uptake, lactate production, pyruvate and acetyl-coenzyme production in colon cancer cells[1]. Ganoderic acid D induces HeLa human cervical carcinoma apoptosis[2].
Anhydrocochlioquinone A
[Raw Data] CBA28_Anhydrocochlioq_pos_50eV_1-2_01_1556.txt [Raw Data] CBA28_Anhydrocochlioq_pos_40eV_1-2_01_1555.txt [Raw Data] CBA28_Anhydrocochlioq_pos_30eV_1-2_01_1554.txt [Raw Data] CBA28_Anhydrocochlioq_pos_20eV_1-2_01_1553.txt [Raw Data] CBA28_Anhydrocochlioq_pos_10eV_1-2_01_1541.txt
(17R,20S,22R)-4beta-hydroxy-1-oxo-5beta,6beta-epoxy-16alpha-acetoxywitha-2-enolide
3beta-O-(beta-D-sarmentosyl)-8,14-epoxy-5beta,14beta-card-16,20(22)-dienolide|cardenolide N-2
Cucurbitacin I
Cucurbitacin i is a member of the class of compounds known as cucurbitacins. Cucurbitacins are polycyclic compounds containing the tetracyclic cucurbitane nucleus skeleton, 19-(10->9b)-abeo-10alanost-5-ene (also known as 9b-methyl-19-nor lanosta-5-ene), with a variety of oxygenation functionalities at different positions. Cucurbitacin i is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Cucurbitacin i can be found in cucumber, which makes cucurbitacin i a potential biomarker for the consumption of this food product. Cucurbitacin I is a natural selective inhibitor of JAK2/STAT3, with potent anti-cancer activity.
7??,23?鈥?Dihydroxy-3,11,15-trioxolanosta-8,20E(22)-dien-26-oic acid
methyl 7beta-hydroxy-3,11,15,23-tetraoxo-5alpha-lanost-8-en-26-oate
(5alpha,6beta,18S,22R)-18,20-epoxy-6,22-dihydroxy-5,18-dimethoxy-1-oxoergosta-2,24-dien-26-oic acid delta-lactone|5-O-methoxywithaphysalin R
3,7,11,15,23-pentaoxolanostan-26-oic acid|8beta,9alpha-dihydroganoderic acid C
(17R,20S,22R)-4beta-hydroxy-1-oxo-5beta,6beta-epoxy-18-acetoxywitha-2-enolide
12-O-tiglyl-4-deoxy-4alpha-phorbol-13-(2-methyl)butyrate
7alpha,12alpha,14beta,15alpha-tetrahydroxyl-ent-kaur-16-ene-1-O-beta-D-glucopyranoside|glaucocalyxin G
(20R)-5alpha-pregnane-2alpha,3alpha,16beta,20-tetrol 2-O-beta-D-glucopyranoside
3beta(H)-1-oxo-7beta,9alpha,13-triangelyloxylongipinane
craiobioside B|craiobiotoxin VIII 3-O-beta-D-glucopyranoside
eudesm-11-en-4alpha-O-beta-D-2-cinnamoyloxy-glucopyranoside|fissipallin
(3beta,5beta,6beta,18S,22R)-5,6:18,20-diepoxy-22-hydroxy-3,18-dimethoxy-1-oxoergost-24-en-26-oic acid delta-lactone|withaphysalin Q
(4aR)-9-((1S)-2cF-Acetoxy-1rF,3tF-dimethyl-pent-catF-yl)-3t-(alpha-hydroxy-isopropyl)-6a,12b-dimethyl-(4ar,6at,12bt)-1,2,3,4a,5,6,6a,12b-octahydro-pyrano[3,2-a]xanthen-8,11-dion|(4aR)-9-((1S)-2cF-acetoxy-1rF,3tF-dimethyl-pent-catF-yl)-3t-(alpha-hydroxy-isopropyl)-6a,12b-dimethyl-(4ar,6at,12bt)-1,2,3,4a,5,6,6a,12b-octahydro-pyrano[3,2-a]xanthene-8,11-dione|anhydroisocochlioquinone A
10(20)-grayanotoxene-3beta,5beta,6beta,14beta,16alpha-pentol 3-O-beta-D-glucopyranoside|rhodomoside A
Ganoderic acid LM2
Ganoderenic acid B
Ganoderenic acid B is a triterpenoid. CID 78074039 is a natural product found in Ganoderma applanatum and Ganoderma lucidum with data available. Ganoderenic acid B is a lanostane-type triterpene isolated from Ganoderma lucidum. Ganoderenic acid B exhibits potent reversal effect on ABCB1-mediated multidrug resistance of HepG2/ADM cells to Doxorubicin[1].
Ganoderenic acid A
Ganoderenic acid A is a triterpenoid. (E)-6-[(7S,10S,13R,14R,15S,17R)-7,15-dihydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohept-5-enoic acid is a natural product found in Ganoderma applanatum and Ganoderma lucidum with data available. Ganoderenic acid A is a lanostane-type triterpene. Ganoderenic acid A is a potent inhibitor of β-glucuronidase. Ganoderenic acid A has a potent hepatoprotective effect against CCl4-induced liver injury[1]. Ganoderenic acid A is a lanostane-type triterpene. Ganoderenic acid A is a potent inhibitor of β-glucuronidase. Ganoderenic acid A has a potent hepatoprotective effect against CCl4-induced liver injury[1].
Ganoderic acid J
C27H46O9_9,12,15-Octadecatrienoic acid, 3-(hexopyranosyloxy)-2-hydroxypropyl ester, (9Z,12Z,15Z)
Cys His Lys Lys
Cys Lys His Lys
Cys Lys Lys His
Asp Lys Pro Arg
Asp Lys Arg Pro
Asp Pro Lys Arg
Asp Pro Arg Lys
Asp Arg Lys Pro
Asp Arg Pro Lys
Phe His Ile Val
Phe His Leu Val
Phe His Val Ile
Phe His Val Leu
Phe Ile His Val
Phe Ile Val His
Phe Leu His Val
Phe Leu Val His
Phe Val His Ile
Phe Val His Leu
Phe Val Ile His
Phe Val Leu His
His Cys Lys Lys
His Phe Ile Val
His Phe Leu Val
His Phe Val Ile
His Phe Val Leu
His Ile Phe Val
His Ile Val Phe
His Lys Cys Lys
His Lys Lys Cys
His Leu Phe Val
His Leu Val Phe
His Val Phe Ile
His Val Phe Leu
His Val Ile Phe
His Val Leu Phe
Ile Phe His Val
Ile Phe Val His
Ile His Phe Val
Ile His Val Phe
Ile Ile Asn Arg
Ile Ile Arg Asn
Ile Leu Asn Arg
Ile Leu Arg Asn
Ile Asn Ile Arg
Ile Asn Leu Arg
Ile Asn Arg Ile
Ile Asn Arg Leu
Ile Gln Arg Val
Ile Gln Val Arg
Ile Arg Ile Asn
Ile Arg Leu Asn
Ile Arg Asn Ile
Ile Arg Asn Leu
Ile Arg Gln Val
Ile Arg Val Gln
Ile Val Phe His
Ile Val His Phe
Ile Val Gln Arg
Ile Val Arg Gln
Lys Cys His Lys
Lys Cys Lys His
Lys Asp Pro Arg
Lys Asp Arg Pro
Lys His Cys Lys
Lys His Lys Cys
Lys Lys Cys His
Lys Lys His Cys
Lys Pro Asp Arg
Lys Pro Arg Asp
Lys Arg Asp Pro
Lys Arg Pro Asp
Leu Phe His Val
Leu Phe Val His
Leu His Phe Val
Leu His Val Phe
Leu Ile Asn Arg
Leu Ile Arg Asn
Leu Leu Asn Arg
Leu Leu Arg Asn
Leu Asn Ile Arg
Leu Asn Leu Arg
Leu Asn Arg Ile
Leu Asn Arg Leu
Leu Gln Arg Val
Leu Gln Val Arg
Leu Arg Ile Asn
Leu Arg Leu Asn
Leu Arg Asn Ile
Leu Arg Asn Leu
Leu Arg Gln Val
Leu Arg Val Gln
Leu Val Phe His
Leu Val His Phe
Leu Val Gln Arg
Leu Val Arg Gln
Asn Ile Ile Arg
Asn Ile Leu Arg
Asn Ile Arg Ile
Asn Ile Arg Leu
Asn Leu Ile Arg
Pro Asp Lys Arg
Pro Asp Arg Lys
Pro Lys Asp Arg
Pro Lys Arg Asp
Pro Arg Asp Lys
Pro Arg Lys Asp
Pro Arg Arg Ser
Pro Arg Ser Arg
Pro Ser Arg Arg
Arg Asp Lys Pro
Arg Asp Pro Lys
Arg Lys Asp Pro
Arg Lys Pro Asp
Arg Pro Asp Lys
Arg Pro Lys Asp
Arg Pro Arg Ser
Arg Pro Ser Arg
Arg Arg Pro Ser
Arg Arg Ser Pro
Arg Ser Pro Arg
Arg Ser Arg Pro
Ser Pro Arg Arg
Ser Arg Pro Arg
Ser Arg Arg Pro
Val Phe His Ile
Val Phe His Leu
Val Phe Ile His
Val Phe Leu His
Val His Phe Ile
Val His Phe Leu
Val His Ile Phe
Val His Leu Phe
Val Ile Phe His
Val Ile His Phe
Val Leu Phe His
Val Leu His Phe
Capsianside V
Cinncassiol D1 glucoside
Cinncassiol D4 2-glucoside
Cofaryloside
Ganoderic acid C
Ganoderic acid Z
Ganosporelactone B
Flavidulol C
Ganoderic acid V1
tert-butyl 1,6-diazaspiro[3.4]octane-1-carboxylate hemioxalate
3-[2-(4-Aminophenyl)ethyl]-8-[4-(4-fluorophenyl)-4-oxobutyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one
Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-
Tauro-beta-muricholate
A cholanic acid conjugate anion that is the conjugate base of tauro-beta-muricholic acid arising from deprotonation of the sulfonate OH group; major species at pH 7.3. D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
9-[(E)-4-[(2S,4R,5R)-4,5-dihydroxy-5-[[3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]-3-oxooxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid
17-[(E)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-2,16-dihydroxy-4,4,9,13,14-pentamethyl-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthrene-3,11-dione
Tauro-alpha-muricholate(1-)
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
(3S,3aR,4S,6aS,7E,10S,11E,13R,14S,15Z,17aS)-13,14-dihydroxy-3-(1H-indol-3-ylmethyl)-4,5,10,12-tetramethyl-3,3a,4,6a,9,10,13,14-octahydro-1H-cyclotrideca[d]isoindole-1,17(2H)-dione
Tauroursocholate
An organosulfonate oxoanion that is the conjugate base of tauroursocholic acid, obtained by the deprotonation of the sulfonic acid group. It is the major microspecies at pH 7.3.
(2S)-N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide
(2S)-N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide
(2S)-N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide
2-(dimethylamino)-N-[(4R,7R,8S)-5-[(2-fluorophenyl)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
(2S)-N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide
(2S)-N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide
N-[(2R,4aS,12aS)-5-methyl-2-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide
(2R)-N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide
(2R)-N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide
N-[(2R,4aR,12aS)-5-methyl-2-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(2S,4aR,12aS)-5-methyl-2-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(2R,4aR,12aR)-5-methyl-2-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide
3-cyclohexyl-1-[[(2R,3S)-8-(3-hydroxyhex-1-ynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea
(2S)-N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide
N-[(2R,4aS,12aR)-5-methyl-2-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(2S,4aR,12aR)-5-methyl-2-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
(2S)-N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide
(2R)-N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide
(2R)-N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide
N-[(2S,4aS,12aS)-5-methyl-2-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(2S,4aS,12aR)-5-methyl-2-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
(2R)-N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide
(2R)-N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide
(2R)-N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methyl-2-phenylpropanamide
(Z)-6-[(3S,5R,7S,10S,13R,14R,17R)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohept-5-enoic acid
(8S,9R,13R,14S,16R,17R)-17-[(E,2R)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-2,16-dihydroxy-4,4,9,13,14-pentamethyl-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthrene-3,11-dione
[2-hydroxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] (9E,12E,15E)-octadeca-9,12,15-trienoate
(2-hydroxy-3-phosphonooxypropyl) (12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoate
(1-phosphonooxy-3-propanoyloxypropan-2-yl) (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate
(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
(1-pentanoyloxy-3-phosphonooxypropan-2-yl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
2-[hydroxy-[2-hydroxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
eurysterol A sulfonic acid
A steroid sulfate that is 5alpha-cholestane substituted by hydroxy groups at positions 5 and 6, a bridged oxolane at positions 8 and 19 pand a sulfate group at position 3.
Taurocholate
An organosulfonate oxoanion that is the conjugate base of taurocholic acid.
LPEt(22:4)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
15-[1-(4,5-dimethyl-6-oxooxan-2-yl)ethyl]-6-hydroxy-2,16-dimethyl-3-oxo-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-14-yl acetate
(2r,5z)-6-[(1s,3as,4r,5as,7r,9ar,11as)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxohept-5-enoic acid
(2z)-6-[(1r,3s,3ar,4s,5ar,9as,11ar)-3,4-dihydroxy-3a,6,6,9a,11a-pentamethyl-7,10-dioxo-1h,2h,3h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-4-hydroxy-2-methylhepta-2,6-dienoic acid
(2s,5e)-6-[(1r,3ar,4s,5ar,7s,9as,11ar)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxohept-5-enoic acid
(2r,6s)-6-[(1r,3ar,4s,5ar,9as,11ar)-4-hydroxy-3a,6,6,9a,11a-pentamethyl-3,7,10-trioxo-1h,2h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid
2-[(3r,4s,5s,6s,7e,9e,11e)-4,6-dimethoxy-3,5,11-trimethyltrideca-7,9,11-trien-1-yl]-8-hydroxy-5,7-dimethoxy-3-methylchromen-4-one
(2s,3s)-1-[(3s,7s,10s,13e)-10-[(2s)-butan-2-yl]-8,11-dihydroxy-16-methoxy-2-oxa-6,9,12-triazatricyclo[13.3.1.0³,⁷]nonadeca-1(18),8,11,13,15(19),16-hexaen-6-yl]-2-(dimethylamino)-3-methylpentan-1-one
(2r,3r,4s,5s,6r)-2-{[(1s,2s,3as,3br,5as,7s,8r,9as,9bs,11as)-2,7-dihydroxy-1-[(1r)-1-hydroxyethyl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-8-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,6r)-6-[(1r,3as,3br,5ar,9as,9bs,11ar)-3a,6,6,9a,11a-pentamethyl-3,4,7,10-tetraoxo-octahydro-1h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid
3,4-dihydroxy-3',3a,4'',6,6,9a,11a-heptamethyl-2,3,4,5,5a,8,9,11-octahydrodispiro[cyclopenta[a]phenanthrene-1,2':5',2''-bis(oxolane)]-5'',7,10-trione
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1s,4s,5r,9s,10r,13s,14s)-13,14-dihydroxy-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate
1,13-dihydroxy-3-(1h-indol-3-ylmethyl)-4,5,10,12-tetramethyl-3h,3ah,4h,6ah,9h,10h,13h,15h,16h-cyclotrideca[d]isoindole-14,17-dione
(1s,4s,5r,8s,9s,10r,13r,14r)-14-hydroxy-14-(hydroxymethyl)-5,9-dimethyl-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid
5'-(1-{1-ethyl-5,6,6-trimethyl-2,7,8-trioxabicyclo[3.2.1]octan-3-yl}ethyl)-6',10'-dimethyl-13'-oxaspiro[oxolane-2,11'-tetracyclo[7.5.0.0²,⁶.0¹²,¹⁴]tetradecan]-8'-ene-5,7'-dione
(3s,3ar,4s,6as,10s,13r,17ar)-1,13-dihydroxy-3-(1h-indol-3-ylmethyl)-4,5,10,12-tetramethyl-3h,3ah,4h,6ah,9h,10h,13h,15h,16h-cyclotrideca[d]isoindole-14,17-dione
(6r)-6-[(1r,3ar,5ar,7s,9as,11ar)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid
6-{4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-2-methyl-4-oxohept-5-enoic acid
(1r,3r,4r,6s,8s,10s,13r,14r)-5,5,14-trimethyl-9-methylidene-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecane-3,4,10,14-tetrol
(1r,4s,5s,6r,9s,10s,13r,14r,15r)-6,14,15-trihydroxy-5,9-dimethyl-14-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carbaldehyde
4,6-bis[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-5-(6-hydroxy-1-benzofuran-2-yl)benzene-1,3-diol
6-{3a,6,6,9a,11a-pentamethyl-3,4,7,10-tetraoxo-octahydro-1h-cyclopenta[a]phenanthren-1-yl}-2-methyl-4-oxoheptanoic acid
(1r,3e,5r,7s,9r,10e,12s,13s,14r)-1-(acetyloxy)-13-hydroxy-3,6,6,10,14-pentamethyl-2-oxotricyclo[10.3.0.0⁵,⁷]pentadeca-3,10-dien-9-yl (2e)-3-[(2s,3r)-3-propyloxiran-2-yl]prop-2-enoate
(3s,3as,6r,7ar)-5-{5-[(5r,6s,7as)-6-ethenyl-3-(hydroxymethyl)-6-methyl-2-oxo-4,5,7,7a-tetrahydro-1-benzofuran-5-yl]hex-5-en-2-yl}-6-ethyl-3-hydroxy-3-(hydroxymethyl)-6-methyl-7,7a-dihydro-3ah-1-benzofuran-2-one
7-hydroxy-12-[1-hydroxy-3-(4-methyl-3,6-dihydro-2h-pyran-2-yl)prop-2-en-1-yl]-3-methyl-5-methylidene-9,13,22-trioxatricyclo[16.3.1.0⁸,¹⁰]docosa-15,19-dien-14-one
15-(1-{2-hydroxy-1,6-dimethyl-3,7-dioxabicyclo[4.1.0]heptan-4-yl}ethyl)-2,16-dimethyl-3-oxo-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-14-yl acetate
(2s,3s,4s)-2-[(2r,4ar,10ar,12ar)-2-(2-hydroxypropan-2-yl)-4a,10a-dimethyl-6,9-dioxo-2,3,4,11,12,12a-hexahydro-1,10-dioxatetraphen-8-yl]-4-methylhexan-3-yl acetate
4,4',6,12,17,17-hexamethyl-9,18,23,24-tetraoxaspiro[hexacyclo[20.2.1.0¹,¹³.0⁴,¹².0⁵,¹⁰.0¹⁶,²²]pentacosane-8,2'-oxolan]-20-ene-5',19-dione
7β,23ξ-dihydroxy-3,11,15-trioxolanosta-8,-20e(22)-dien-26-oicacid
{"Ingredient_id": "HBIN013082","Ingredient_name": "7\u03b2,23\u03be-dihydroxy-3,11,15-trioxolanosta-8,-20e(22)-dien-26-oicacid","Alias": "NA","Ingredient_formula": "C30H42O7","Ingredient_Smile": "CC(CC(C=C(C)C1CC(=O)C2(C1(CC(=O)C3=C2C(CC4C3(CCC(=O)C4(C)C)C)O)C)C)O)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6167","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}